Literature DB >> 15113441

Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.

Alice J Sigurdson1, Michael Hauptmann, Nilanjan Chatterjee, Bruce H Alexander, Michele Morin Doody, Joni L Rutter, Jeffery P Struewing.   

Abstract

BACKGROUND: Subtle functional deficiencies in highly conserved DNA repair or growth regulatory processes resulting from polymorphic variation may increase genetic susceptibility to breast cancer. Polymorphisms in DNA repair genes can impact protein function leading to genomic instability facilitated by growth stimulation and increased cancer risk. Thus, 19 single nucleotide polymorphisms (SNPs) in eight genes involved in base excision repair (XRCC1, APEX, POLD1), BRCA1 protein interaction (BRIP1, ZNF350, BRCA2), and growth regulation (TGFss1, IGFBP3) were evaluated.
METHODS: Genomic DNA samples were used in Taqman 5'-nuclease assays for most SNPs. Breast cancer risk to ages 50 and 70 were estimated using the kin-cohort method in which genotypes of relatives are inferred based on the known genotype of the index subject and Mendelian inheritance patterns. Family cancer history data was collected from a series of genotyped breast cancer cases (N = 748) identified within a cohort of female US radiologic technologists. Among 2,430 female first-degree relatives of cases, 190 breast cancers were reported.
RESULTS: Genotypes associated with increased risk were: XRCC1 R194W (WW and RW vs. RR, cumulative risk up to age 70, risk ratio (RR) = 2.3; 95% CI 1.3-3.8); XRCC1 R399Q (QQ vs. RR, cumulative risk up to age 70, RR = 1.9; 1.1-3.9); and BRIP1 (or BACH1) P919S (SS vs. PP, cumulative risk up to age 50, RR = 6.9; 1.6-29.3). The risk for those heterozygous for BRCA2 N372H and APEX D148E were significantly lower than risks for homozygotes of either allele, and these were the only two results that remained significant after adjusting for multiple comparisons. No associations with breast cancer were observed for: APEX Q51H; XRCC1 R280H; IGFPB3 -202A>C; TGFss1 L10P, P25R, and T263I; BRCA2 N289H and T1915M; BRIP1 -64A>C; and ZNF350 (or ZBRK1) 1845C>T, L66P, R501S, and S472P.
CONCLUSION: Some variants in genes within the base-excision repair pathway (XRCC1) and BRCA1 interacting proteins (BRIP1) may play a role as low penetrance breast cancer risk alleles. Previous association studies of breast cancer and BRCA2 N372H and functional observations for APEX D148E ran counter to our findings of decreased risks. Due to the many comparisons, cautious interpretation and replication of these relationships are warranted.

Entities:  

Mesh:

Year:  2004        PMID: 15113441      PMCID: PMC408462          DOI: 10.1186/1471-2407-4-9

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  41 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

3.  XRCC1 genetic polymorphism and breast cancer risk.

Authors:  Sook-Un Kim; Sue Kyung Park; Keun-Young Yoo; Kyung-Sik Yoon; Ji Yeob Choi; Jeong-Sun Seo; Woong-Yong Park; Ju-Han Kim; Dong-Young Noh; Se-Hyun Ahn; Kuk-Jin Choe; Paul T Strickland; Ari Hirvonen; Daehee Kang
Journal:  Pharmacogenetics       Date:  2002-06

Review 4.  Polymorphisms in DNA repair genes and associations with cancer risk.

Authors:  Ellen L Goode; Cornelia M Ulrich; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

5.  Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.

Authors:  A C Antoniou; P D Pharoah; G McMullan; N E Day; B A Ponder; D Easton
Journal:  Genet Epidemiol       Date:  2001-07       Impact factor: 2.135

6.  BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk.

Authors:  Annika Auranen; Amanda B Spurdle; Xiaoqing Chen; Julian Lipscombe; David M Purdie; John L Hopper; Adele Green; Catherine S Healey; Karen Redman; Alison M Dunning; Paul D Pharoah; Douglas F Easton; Bruce A J Ponder; Georgia Chenevix-Trench; Karen L Novik
Journal:  Int J Cancer       Date:  2003-01-20       Impact factor: 7.396

7.  Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans.

Authors:  Harvey W Mohrenweiser; Tong Xi; Johana Vázquez-Matías; Irene M Jones
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

8.  Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer.

Authors:  Tasha R Smith; Mark Steven Miller; Kurt Lohman; Ethan M Lange; L Douglas Case; Harvey W Mohrenweiser; Jennifer J Hu
Journal:  Cancer Lett       Date:  2003-02-20       Impact factor: 8.679

9.  Kin-cohort evaluation of relative risks of genetic variants.

Authors:  Catherine L Saunders; Colin B Begg
Journal:  Genet Epidemiol       Date:  2003-04       Impact factor: 2.135

10.  Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair.

Authors:  Richard M Taylor; Angela Thistlethwaite; Keith W Caldecott
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

View more
  34 in total

1.  Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses.

Authors:  Montserrat García-Closas; Kathleen M Egan; Polly A Newcomb; Louise A Brinton; Linda Titus-Ernstoff; Stephen Chanock; Robert Welch; Jolanta Lissowska; Beata Peplonska; Neonila Szeszenia-Dabrowska; Witold Zatonski; Alicja Bardin-Mikolajczak; Jeffery P Struewing
Journal:  Hum Genet       Date:  2006-02-17       Impact factor: 4.132

Review 2.  Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  David J Hughes
Journal:  Fam Cancer       Date:  2008-02-19       Impact factor: 2.375

Review 3.  G-quadruplex nucleic acids and human disease.

Authors:  Yuliang Wu; Robert M Brosh
Journal:  FEBS J       Date:  2010-07-29       Impact factor: 5.542

4.  Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation.

Authors:  Frank Weber; Lei Shen; Koichi Fukino; Attila Patocs; George L Mutter; Trinidad Caldes; Charis Eng
Journal:  Am J Hum Genet       Date:  2006-04-12       Impact factor: 11.025

Review 5.  Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1.

Authors:  Sharon B Cantor; Shawna Guillemette
Journal:  Future Oncol       Date:  2011-02       Impact factor: 3.404

Review 6.  Impact of DNA polymorphisms in key DNA base excision repair proteins on cancer risk.

Authors:  B Karahalil; V A Bohr; D M Wilson
Journal:  Hum Exp Toxicol       Date:  2012-09-27       Impact factor: 2.903

7.  The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer.

Authors:  Denise L Stredrick; Montserrat Garcia-Closas; Marbin A Pineda; Parveen Bhatti; Bruce H Alexander; Michele M Doody; Jolanta Lissowska; Beata Peplonska; Louise A Brinton; Stephen J Chanock; Jeffery P Struewing; Alice J Sigurdson
Journal:  Hum Mutat       Date:  2006-06       Impact factor: 4.878

8.  XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study.

Authors:  Jennifer Zipprich; Mary Beth Terry; Paul Brandt-Rauf; Greg A Freyer; Yuyan Liao; Meenakshi Agrawal; Irina Gurvich; Ruby Senie; Regina M Santella
Journal:  J Carcinog       Date:  2010-04-16

9.  Insight into the roles of helicase motif Ia by characterizing Fanconi anemia group J protein (FANCJ) patient mutations.

Authors:  Manhong Guo; Venkatasubramanian Vidhyasagar; Hao Ding; Yuliang Wu
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

10.  Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.

Authors:  A M Ray; K A Zuhlke; G R Johnson; A M Levin; J A Douglas; E M Lange; K A Cooney
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.